scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH · Real-Time Price · USD
3.390
+0.080 (2.42%)
At close: Dec 20, 2024, 4:00 PM
3.410
+0.020 (0.59%)
After-hours: Dec 20, 2024, 4:10 PM EST
scPharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
Cash & Equivalents | 91.48 | 46.81 | 71.06 | 74.27 | 71.82 | 72.62 | Upgrade
|
Short-Term Investments | 1.15 | 30.18 | 48.55 | 1.03 | 33.28 | - | Upgrade
|
Cash & Short-Term Investments | 92.63 | 76.99 | 119.61 | 75.3 | 105.1 | 72.62 | Upgrade
|
Cash Growth | 1.28% | -35.63% | 58.85% | -28.35% | 44.71% | -18.84% | Upgrade
|
Accounts Receivable | 9.22 | 4.49 | - | - | - | - | Upgrade
|
Other Receivables | - | - | - | - | - | 0.31 | Upgrade
|
Receivables | 9.22 | 4.49 | - | - | - | 0.31 | Upgrade
|
Inventory | 18.11 | 8.84 | 1.23 | - | - | - | Upgrade
|
Prepaid Expenses | 3.37 | 2.44 | 2.28 | 2.79 | 2.61 | 2.62 | Upgrade
|
Restricted Cash | - | - | 0.18 | 0.18 | - | - | Upgrade
|
Other Current Assets | - | 0.18 | - | - | 0.12 | 0.09 | Upgrade
|
Total Current Assets | 123.33 | 92.94 | 123.31 | 78.28 | 107.83 | 75.65 | Upgrade
|
Property, Plant & Equipment | 1.38 | 1.46 | 0.62 | 0.48 | 0.91 | 1.31 | Upgrade
|
Other Long-Term Assets | 0.36 | 0.08 | 0.27 | 0.28 | 0.31 | 0.33 | Upgrade
|
Total Assets | 125.07 | 94.48 | 124.2 | 79.04 | 109.05 | 77.28 | Upgrade
|
Accounts Payable | 5 | 4 | 1.52 | 0.54 | 1.67 | 1.14 | Upgrade
|
Accrued Expenses | 9.87 | 8.75 | 5.29 | 3.99 | 4.75 | 3.64 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | 9.81 | 2.41 | - | Upgrade
|
Current Portion of Leases | 0.23 | 0.18 | 0.57 | 0.48 | 0.46 | 0.41 | Upgrade
|
Current Income Taxes Payable | - | - | - | 0.01 | 0.04 | 0.05 | Upgrade
|
Other Current Liabilities | 0.16 | 0.21 | 0.04 | 0.03 | - | - | Upgrade
|
Total Current Liabilities | 15.26 | 13.13 | 7.42 | 14.85 | 9.32 | 5.24 | Upgrade
|
Long-Term Debt | 51.1 | 38.81 | 36.79 | 7.35 | 16.86 | 19.68 | Upgrade
|
Long-Term Leases | 1.17 | 1.28 | 0.01 | - | 0.48 | 0.94 | Upgrade
|
Other Long-Term Liabilities | 26.83 | 4.03 | 7.55 | 0.37 | 0.22 | 0.06 | Upgrade
|
Total Liabilities | 94.36 | 57.26 | 51.76 | 22.57 | 26.88 | 25.92 | Upgrade
|
Common Stock | 0.01 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 378.35 | 318.56 | 298.93 | 246.17 | 243.83 | 180.82 | Upgrade
|
Retained Earnings | -347.65 | -281.35 | -226.54 | -189.7 | -161.66 | -129.46 | Upgrade
|
Comprehensive Income & Other | - | -0 | 0.03 | -0 | 0 | - | Upgrade
|
Total Common Equity | 30.71 | 37.22 | 72.43 | 56.47 | 82.17 | 51.37 | Upgrade
|
Shareholders' Equity | 30.71 | 37.22 | 72.43 | 56.47 | 82.17 | 51.37 | Upgrade
|
Total Liabilities & Equity | 125.07 | 94.48 | 124.2 | 79.04 | 109.05 | 77.28 | Upgrade
|
Total Debt | 52.5 | 40.27 | 37.37 | 17.64 | 20.21 | 21.03 | Upgrade
|
Net Cash (Debt) | 40.14 | 36.72 | 82.25 | 57.67 | 84.89 | 51.59 | Upgrade
|
Net Cash Growth | -22.29% | -55.35% | 42.62% | -32.07% | 64.53% | -33.97% | Upgrade
|
Net Cash Per Share | 0.98 | 0.95 | 2.90 | 2.11 | 3.46 | 2.77 | Upgrade
|
Filing Date Shares Outstanding | 50.04 | 36.05 | 35.77 | 27.37 | 27.36 | 20.98 | Upgrade
|
Total Common Shares Outstanding | 50.04 | 35.97 | 34.26 | 27.37 | 27.33 | 18.57 | Upgrade
|
Working Capital | 108.07 | 79.8 | 115.89 | 63.43 | 98.51 | 70.41 | Upgrade
|
Book Value Per Share | 0.61 | 1.03 | 2.11 | 2.06 | 3.01 | 2.77 | Upgrade
|
Tangible Book Value | 30.71 | 37.22 | 72.43 | 56.47 | 82.17 | 51.37 | Upgrade
|
Tangible Book Value Per Share | 0.61 | 1.03 | 2.11 | 2.06 | 3.01 | 2.77 | Upgrade
|
Machinery | 0.12 | 0.11 | 0.15 | 0.14 | 0.13 | 0.13 | Upgrade
|
Leasehold Improvements | 0.01 | 0.01 | 0.1 | 0.1 | 0.1 | 0.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.